Extended Time Period for DePuy Knee Sleeve Failure Lawsuit Allegation Complimentary Consultations Announced by Resource4thePeople Attorneys

Share Article

Nationwide network of attorneys announces increased number of consumers may be eligible to seek compensation over allegations that DePuy Orthopaedics LPS Diaphyseal Knee Sleeve systems failed and may have caused serious side effects.

http://www.resource4thepeople.com/defectivemedicaldevices/depuy-knee-sleeve-lawsuits.html

Resource4thePeople announced today that there is an increased time period involved in which consumers may seek free consultations over claims that they allegedly suffered serious health problems from DePuy knee sleeves.

The announcement comes in response to numerous inquiries from consumers who are attempting to clarify their status in the wake of a Class 1 Recall issued by the U.S. Food and Drug Administration of the DePuy Orthopaedics LPS Diaphyseal Knee Sleeve in which authorities warned* that the failure of the device could have life-threatening consequences.

"The FDA's announcement came on Feb. 22, 2013 and has generated a huge response from consumers who may have been affected by the serious side effects outlined by the FDA in its recall notice," said Resource4thePeople.

"We are making this announcement to clear up any confusion consumers have been voicing about their eligibility to seek compensation for medical costs."

Resource4thePeople said consumer cases from before the Feb. 22, 2013 recall notice date are eligible for complimentary consultations about legal eligibility.

"Every case is different, of course, but we want to assure consumers that we will continue to review cases in which alleged side effects occurred before that date," said Resource4thePeople.

"The side effects that the FDA warns about in its recall notice reflect life-threatening allegations that involve medical conditions that our attorneys are actively seeking compensation for on behalf of our clients."

FDA officials, in their “Reason for Recall” warned that health complications as drastic as death could occur if this device malfunctions, said Resource4thePeople.

“The LPS Diaphyseal Sleeve to Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients,” the FDA said in its warning.

“This may result in fracture of the sleeve at the taper joint which may also lead to loss of function or loss of limb, infection, compromised soft tissue or death.”

“The increase in the inquiries we have been receiving from consumers who may have been affected by this recall centers on questions about what legal compensation they may be eligible to receive," said Resource4thePeople.

“This is the most serious type of recall by FDA regulators and we are encouraging patients who may have suffered these dangerous side effects to fully inform themselves about what legal rights they may have to seek compensation in this situation.”

The consultations may provide consumers with information about the legal options they may be entitled to in seeking compensation for medical costs, pain and suffering, loss of wages and other costs that may have been incurred.

The DePuy Orthopaedics LPS Diaphyseal Knee Sleeve is described by the manufacturer as an end-stage revision knee device that has been used in numerous operations by surgeons who are reconstructing severe soft tissue and bony defects. The diaphyseal sleeve is intended to enhance the fit and fill of the diaphyseal femoral canal with femoral and tibial replacements.

The FDA issued the Class 1 Recall of the DePuy Orthopaedics LPS Diaphyseal Knee Sleeve in an urgent notification to health care professionals and consumers.

The FDA in the announcement describes Class I Recalls as the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

The FDA said in its announcement that the LPS Diaphyseal Sleeve to Diaphyseal Sleeve Base taper connection may not be sufficient to accommodate potential physiologic loads that may be transferred to the junction during normal gait activities by some patients.

The FDA said it acted after receiving 10 reports (6 fractures and 4 reports of loosening that may or may not be attributed to the same device design issue) of incidents in which the device has malfunctioned.

DePuy has informed the FDA that the affected devices were manufactured from 2008 to July 20, 2012 and that it has recommended that hospitals and surgeons immediately stop distributing or using the recalled lots.

Resource4thePeople attorneys are investigating the following side effects that DePuy has identified as adverse events in connection with the use of the DePuy knee sleeve with the DePuy Limb Preservation System:**

"Some of the most common adverse events associated with the device include a change in the position of the components, loosening, bending, cracking, fracture, deformation or wear of components, fatigue fractions, infection, tissue reaction to wear debris, pain, dislocation, decreased range of motion and loss of limb."

“Patients and health care professionals place their trust in the integrity of medical devices but on some occasions these devices can malfunction,” said Resource4thePeople.

“In such cases consumers or loved ones who may have been injured as a result of a failed or recalled device should know that there are legal options available to them to seek compensation and we will actively update them about their legal rights and future developments affecting this product.”

DePuy also recalled*** thousands of its metal-on-metal hip implant systems in 2010 and thousands of DePuy metal-on-metal hip implant lawsuits have been filed by patients alleging injuries in a federal court system multi-district litigation.****

Bloomberg News, in a Jan. 18, 2013 analysis***** of the litigation, said that DePuy’s parent company, Johnson & Johnson is defending itself against more than 10,000 lawsuits over the recalled hip implants and may face over $2 billion in legal costs.

Sources:
*http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm340708.htm Feb. 22, 2013
**http://www.gsortho.org/files/dpy_lps_limb_preservation_sys_surgtech_0612-36-500r3.pdf
*** http://www.depuy.com/asr-hip-replacement-recall
**** DePuy Orthopaedics Multidistrict Litigation # MDL 2197 U.S. District Court, Northern District of Ohio
***** http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Bill Callahan
iLawSuit
858 602-2749
Email >
Visit website